News blog

US regulators approve next-generation sequencer for clinical use

The US Food and Drug Administration (FDA) has issued its first approval of a next-generation sequencing platform to be used for clinical diagnosis, the agency announced on 19 November. 

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE